For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Tuberculosis is a highly infectious bacterial infection, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. Tuberculosis (TB) can be caught by breathing in air that an infected person has contaminated through: Breathing, coughing. Furthermore, the disease is ranked second leading cause of death, after human immunodeficiency virus (HIV). Individual majorly suffer from two predominant forms of TB: Active tuberculosis and Latent tuberculosis. The global tuberculosis testing market comprises diagnostic tests, equipment's and testing procedures that contribute assistance in diagnostic of tuberculosis infection.
Scope of the Report:
This report studies the Tuberculosis Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tuberculosis Testing market by product type and applications/end industries.
The global Tuberculosis Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tuberculosis Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Abbott Laboratories
- Akonni Biosystems, Inc.
- Alere, Inc.
- Becton, Dickinson and Company
- Cepheid
- Epistem Holdings Plc
- F. Hoffmann-La Roche AG
- Thermo Fischer Scientific Inc.
- bioMérieux SA
- Siemens Healthineer Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Smear Microscopy
- Nucleic Acid Testing
- Radiography
- Culture Based Tests
- Drug Susceptibility Testing
- Others
Market Segment by Applications, can be divided into
- Hospitals
- Laboratories
- Others